Clinical Trials on Multiple Myeloma Progression in Japan
Total 305 results
-
National Center of Neurology and Psychiatry, JapanCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveJapan
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
TakedaCompletedRelapsed/Refractory Multiple MyelomaJapan
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Belgium, Italy, Korea, Republic of, Hong Kong, Israel, Finland, Spain, Japan, United States
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
PfizerActive, not recruitingRelapsed or Refractory Multiple MyelomaJapan
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid LeukemiaJapan
-
Shinshu UniversityRecruitingOsteoarthritis of Multiple Joints | Progression of Rheumatoid ArthritisJapan
-
Otsuka Pharmaceutical Co., Ltd.RecruitingMultiple Myeloma (MM)Japan
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Japan
-
AbbVieActive, not recruiting
-
SymBio PharmaceuticalsCompletedRelapsed/Refractory Multiple MyelomaJapan
-
Novartis PharmaceuticalsActive, not recruitingRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Kobe UniversityRecruitingCoronary Artery Disease ProgressionJapan
-
Kyorin UniversityCompletedDisease Progression | Autosomal Dominant Polycystic Kidney DiseaseJapan
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
TakedaCompleted
-
Janssen Pharmaceutical K.K.CompletedMultiple MyelomaJapan
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple Sclerosis (SPMS)Japan
-
Janssen Pharmaceutical K.K.Completed
-
Novartis PharmaceuticalsActive, not recruitingMultiple Myeloma (MM)United States, Italy, Israel, Germany, Japan, Spain, Australia, Norway
-
CelgeneCompleted
-
Bristol-Myers SquibbCompleted
-
GlaxoSmithKlineActive, not recruiting
-
AmgenCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaCanada, Belgium, Spain, United States, Korea, Republic of, Australia, Czechia, Taiwan, Hungary, Austria, Romania, Japan, United Kingdom, Greece, Turkey, Bulgaria, France, Russian Federation, Poland
-
Kobe UniversityCompletedCoronary Artery Disease ProgressionJapan
-
SanofiActive, not recruitingRelapsed/Refractory Multiple MyelomaAustralia, Czechia, Brazil, Japan, Greece, Portugal
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
SanofiRecruitingMultiple SclerosisKorea, Republic of, United States, China, Turkey, Canada, Australia, Puerto Rico, United Kingdom, Japan, Brazil
-
Kyowa Kirin Co., Ltd.CompletedMultiple Myeloma and Malignant LymphomaJapan
-
TakedaCompleted
-
Eli Lilly and CompanyCompleted
-
SymBio PharmaceuticalsTerminated
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.TerminatedMultiple MyelomaJapan
-
Janssen Pharmaceutical K.K.Completed
-
Novartis PharmaceuticalsCompletedRelapse/Refractory Multiple MyelomaJapan
-
Novartis PharmaceuticalsTerminatedNeoplasms, HaematologicJapan
-
Bristol-Myers SquibbCompleted
-
CelgeneCompleted
-
SanofiRecruitingPrimary Progressive Multiple SclerosisSpain, Italy, Turkey, India, Israel, Bulgaria, Mexico, Greece, Portugal, United States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Estonia, France, Georgia, Germany, Hungary, Japan and more
-
Daiichi Sankyo Co., Ltd.CompletedFibrodysplasia Ossificans ProgressivaJapan
-
PfizerActive, not recruitingLymphoma | Multiple MyelomaJapan
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
Daiichi Sankyo Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
Novartis PharmaceuticalsCompletedMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaItaly, Australia, Germany, Spain, France, Japan, United States